Telix Pharmaceuticals Limited Basic Earnings Loss Per Share
Telix Pharmaceuticals Limited (TLPPF) reported Basic Earnings Loss Per Share of -$0.02 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:BasicEarningsLossPerShare · last filed 2026-02-20
AUD/shares
| Period end | Basic Earnings Loss Per Share 12 month |
|---|---|
| 2024-12-31 | 15.07 AUD/shares 20-F · filed 2025-02-24 |
| 2023-12-31 | 1.63 AUD/shares 20-F · filed 2025-02-24 |
| 2022-12-31 | -33.50 AUD/shares 20-F · filed 2025-02-24 |
USD/shares
| Period end | Basic Earnings Loss Per Share 12 month |
|---|---|
| 2025-12-31 | -$0.02 20-F · filed 2026-02-20 |
| 2024-12-31 | $0.10 20-F · filed 2026-02-20 |
| 2023-12-31 | $0.01 20-F · filed 2026-02-20 |